Skip to main content
ConductScienceScienceDex

Namal Liyanage

NIH Rank #11626
Unclaimed recordClaim profile
  • Program Leader
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 14201079Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • OTHER HEALTH PROFESSIONS
  • Microbiology & Immunology

NIH Funding · FY2025

Linked Award Amount
$1.4M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#11,626
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Namal Liyanage. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Namal Liyanage as a PI. Multi-PI records show the full award amount for context.

  • 5U01AI168630-04U01
    The role of Trained Immunity and Mitochondrial dysfunction on INnate immunity in children and adolescents aGing with PHIV (TIMING-PHIV)
    Ohio State University
    $747.2K
    award amount
  • 1R21AI186957-01A1R21
    Enhanced Antibody-Dependent Cellular Cytotoxicity in HIV Vaccine by Novel Adjuvant
    Ohio State University
    $433.1K
    award amount
  • 5R21TW012876-02R21
    Understanding the Mechanism of HIV Associated with Diabetic Complications in Low- and Middle-Income Country
    Ohio State University
    $179.1K
    award amount

Award organization

Organizations that administered FY2025 awards listing Namal Liyanage as a PI.

FY2025 award administered by Ohio State University (OH).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Ohio State University
  2. 2024
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    Program/Center Grant Leader

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Namal Liyanage.

Nicholas T. Funderburg
Ohio State University
3
shared awards
Sahera Dirajlal-fargo
Ohio State University
3
shared awards

Explore further

Find collaborators for Namal Liyanage

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →